drugset / Trial / NCT05736081

Short-term Effect of Intravitreal Dexamethasone Implant in Refractory Diabetic Macular Edema

NCT05736081 ↗

Phase 4 Completed 15 enrolled Asociación para Evitar la Ceguera en México
NaSingle-groupOpen-labelTreatment

Summary

The goal of this clinical trial es to learn about the short term effects of intravitreal dexamethasone implant (IDI) in patients with refractory diabetic macular edema. The main question it aims to answer is: How fast does the diminishing in central retinal thickness has statistical significance after IDI in patients with refractory diabetic macular edema? Patients will be evaluated by OCT before and after the implant.

Timeline

Start
2018-02-15
Primary completion
2019-06-30
Completion
2019-06-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 0.7 mg Intravitreal